Why Is Adoption of Defibrillators Increasing in Hospitals and Clinics?

The growth of the defibrillator market is driven by several key factors, such as the rising incidence of cardiac diseases, increasing improvements in the defibrillation technology, booming population of the elderly, and surging strategic development activities among major players. These factors will propel the market at a CAGR of 7.2% during the forecast period (2020–2030). The market generated $9,621.2 million in 2019, and it is expected to reach $20,281.6 million by 2030.

Receive Sample Pages: https://www.psmarketresearch.com/market-analysis/defibrillator-market-forecast/report-sample

Hospitals, clinics, and cardiac centers are the largest users of defibrillators, as they regularly adopt advanced medical equipment that offers higher efficiency, for a lower death rate. Apart from this, defibrillators of various types are available at public-access settings, pre-hospital care settings, and homecare settings. The different types of defibrillators include implantable cardioverter defibrillators (ICDs), such as transvenous ICDs (T-ICDs) and subcutaneous ICDs (S-ICDs), and external defibrillators, including manual and automated ones (AEDs).

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=defibrillator-market-forecast

The high incidence of cardiac diseases is an outcome of smoking habits, escalating obesity levels, sedentary lifestyle, and increasing consumption of high-calorie food. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) account for more than 17.9 million deaths across the world. The international body also states that deaths from CVDs will reach nearly 23.6 million by 2030. The primary cause of CVD deaths is coronary heart disease (CHD), followed by stroke and heart failure.

On account of the increasing usage, medical device organizations are constantly developing advanced and easy-to-use defibrillators. One such variant is the BeneHeart C Series AED launched in September 2019 by Shenzhen Mindray Bio-Medical Electronics Co. Ltd. It is designed to improve resuscitation outcomes in cases of SCA via the use of the ResQNavi technology that directs users through the rescue process via voice prompts and step-by-step animation.

Thus, the increasing prevalence of CVDs, developing healthcare infrastructure, and rising R&D on the defibrillation technology will augment the demand for these medical devices in the coming years.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com

This release was published on openPR.